Elevated levels of some pro-inflammatory cytokines e.g., interleukin (IL)-1β, IL-6, tumor necrosis factor (TNF)-α, and IL-18 have been observed in AMD patients and have been proposed as biomarkers for the disease [5,25,27,28,29]. This evidence concerns the gene IL6 and age-related macular degeneration.